Hastings Family Care recently was listed as one of two Nebraska organizations to receive the American Heart Association’s (AHA) Target: Type 2 Diabetes Gold Achievement Award and the 2024 Check. Change. Control. Cholesterol™ Recognition.
The diabetes award was given because Hastings Family Care showed a commitment to improving the quality of care for diabetes patients and lowering cholesterol through improved care for its other patients.
“At Hastings Family Care, providing quality patient care is our priority. That’s why we’ve made a commitment to turn Type 2 diabetes treatment guidelines into lifelines and help more patients lower their cholesterol,” said Jessica Sutton, Director of Clinic Operations. “We are pleased to be recognized by the American Heart Association for our success in meeting evidence-based clinical guidelines developed to improve patient outcomes.”
Cardiovascular disease is the leading cause of death and a major cause of heart attacks, strokes and heart failure for people living with Type 2 diabetes – yet in a survey of people age 45 and older with type 2 diabetes conducted by The Harris Poll, only half recognize their risk or have discussed their risk for heart attack or stroke with their healthcare providers.
Target: Type 2 Diabetes addresses heart disease and stroke risk factors in patients with Type 2 diabetes as part of the Know Diabetes by Heart™ initiative, by the American Heart Association and American Diabetes Association. Target: Type 2 Diabetes puts the unparalleled expertise of the American Heart Association to work for hospitals nationwide, helping ensure the care provided to patients is aligned with the latest evidence- and research-based guidelines.
Each year, program participants apply for award recognition by demonstrating how their organization has committed to providing quality outpatient care for people with Type 2 diabetes. In addition to following treatment guidelines, Target: Type 2 Diabetes participants also empower patients with evidence-based information and tools.
High cholesterol is a major risk factor for cardiovascular disease and stroke, the No. 1 and No. 5 killers in the U.S.
This Check. Change. Control initiative aims to improve awareness, detection and management of high cholesterol by educating and empowering consumers, healthcare professionals and patients with evidence-based information and tools, while also improving quality of care for patients through AHA’s quality improvement programs.
